Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Clinical Trial

Research Support, Non-U.S. Gov't

Comparative Study

Multicenter Study

Review

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, P.H.S.

Observational Study

Controlled Clinical Trial

Letter

Validation Study

Clinical Trial, Phase IV

Publication Year

From

Quick links

Individual year

2024

2019

2018

2016

2014

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Doxazosin""[mesh_terms]

58 Results

Searching titles within these results

Three drugs and still hypertensive: what's left?

Ricky Turgeon, Scott Garrison, G Michael Allan

Canadian family physician Medecin de famille canadien 2018;62(11):904

Free Full Text

Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.

Giuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, Carmine Tinelli, Leonardina Ciccarelli, Mario N Piccinni, Fabio Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, Simona Galli, Sonia Paniga, Roberto Fogari

Journal of cardiovascular pharmacology 2006;47(4):508-12

Full Text

Abstract

Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study.

Melih Basar, Refik Demirtunc, Dursun Duman

Clinical drug investigation 2007;27(6):435-41

Full Text

Abstract

Doxazosin and congestive heart failure.

Domenic A Sica

Congestive heart failure (Greenwich, Conn.) 2002;8(3):178-84

Free Full Text

Abstract

Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation.

Norio Komai, Mitsuru Ohishi, Atsushi Moriguchi, Yoshihiro Yanagitani, Toyohisa Jinno, Keiko Matsumoto, Tomohiro Katsuya, Hiromi Rakugi, Jitsuo Higaki, Toshio Ogihara

Hypertension research : official journal of the Japanese Society of Hypertension 2002;25(1):5-10

Free Full Text

Abstract

Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

S Dutkiewics

International urology and nephrology 2002;32(3):423-32

Full Text

Abstract

Reducing Arterial Stiffness Independently of Blood Pressure: The VaSera Trial.

Charlotte E Mills, Virginia Govoni, Luca Faconti, Maria-Linda Casagrande, Steven V Morant, Andrew J Webb, J Kennedy Cruickshank

Journal of the American College of Cardiology 2019;70(13):1683-1684

Free Full Text

Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.

L N Türkeri, M Ozyürek, D Ersev, A Akdaş

Archivos espanoles de urologia 2001;54(2):191-6

Full Text

Abstract

Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients.

A Martínez Castelao, M Ibernón, X Sarrias, V Sanz, F Moreso, I Rama, J M Grinyó

Transplantation proceedings 2004;35(5):1736-8

Full Text

Abstract

Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism.

T Inukai, Y Inukai, R Matsutomo, K Okumura, K Takanashi, K Takebayashi, K Tayama, Y Aso, Y Takemura

The Journal of international medical research 2004;32(2):206-13

Free Full Text

Abstract

Effect of doxazosin on insulin resistance in hypertensive patients with obesity.

H Ueshiba, Y Miyachi

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2004;35(9):532-6

Full Text

Abstract

Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients.

Michał Nowicki, Tomasz Waluś, Franciszek Kokot

Kidney & blood pressure research 2002;25(1):55-60

Full Text

Abstract

Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension.

I Nalbantgil, R Onder, S Nalbantgil

American journal of hypertension 2001;13(8):921-6

Full Text

Abstract

The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.

Erdal Yilmaz, Ertan Batislam, Mehmed Murad Basar, Devrim Tuglu, Mehmet Ferhat, Halil Basar

The Journal of urology 2005;173(6):2010-2

Full Text

Abstract

Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study.

A Yildiz, M Hursit, A V Celik, S M Kayacan, H Yazici, V Akkaya, A O Gürol, K Karsidag

Clinical nephrology 2003;58(6):405-10

Full Text

Abstract

Results: 1 – 15 / 58

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Doxazosin""[mesh_terms]

Three drugs and still hypertensive: what's left?

Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.

Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study.

Doxazosin and congestive heart failure.

Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation.

Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

Reducing Arterial Stiffness Independently of Blood Pressure: The VaSera Trial.

Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.

Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients.

Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism.

Effect of doxazosin on insulin resistance in hypertensive patients with obesity.

Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients.

Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension.

The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.

Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study.

Results for
""Doxazosin""[mesh_terms]